» Articles » PMID: 27822116

The Danish Sarcoma Database

Overview
Journal Clin Epidemiol
Publisher Dove Medical Press
Specialty Public Health
Date 2016 Nov 9
PMID 27822116
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The aim of the database is to gather information about sarcomas treated in Denmark in order to continuously monitor and improve the quality of sarcoma treatment in a local, a national, and an international perspective.

Study Population: Patients in Denmark diagnosed with a sarcoma, both skeletal and ekstraskeletal, are to be registered since 2009.

Main Variables: The database contains information about appearance of symptoms; date of receiving referral to a sarcoma center; date of first visit; whether surgery has been performed elsewhere before referral, diagnosis, and treatment; tumor characteristics such as location, size, malignancy grade, and growth pattern; details on treatment (kind of surgery, amount of radiation therapy, type and duration of chemotherapy); complications of treatment; local recurrence and metastases; and comorbidity. In addition, several quality indicators are registered in order to measure the quality of care provided by the hospitals and make comparisons between hospitals and with international standards.

Descriptive Data: Demographic patient-specific data such as age, sex, region of living, comorbidity, World Health Organization's International Classification of Diseases - tenth edition codes and TNM Classification of Malignant Tumours, and date of death (after yearly coupling to the Danish Civil Registration System). Data quality and completeness are currently secured.

Conclusion: The Danish Sarcoma Database is population based and includes sarcomas occurring in Denmark since 2009. It is a valuable tool for monitoring sarcoma incidence and quality of treatment and its improvement, postoperative complications, and recurrence within 5 years follow-up. The database is also a valuable research tool to study the impact of technical and medical interventions on prognosis of sarcoma patients.

Citing Articles

The Influence of Danish Cancer Patient Pathways on Survival in Deep-Seated, High-Grade Soft-Tissue Sarcomas in the Extremities and Trunk Wall: A Retrospective Observational Study.

Thorn A, Seem K, Talman M, Engelmann B, Sorensen M, Aggerholm-Pedersen N Cancers (Basel). 2024; 16(23).

PMID: 39682262 PMC: 11640243. DOI: 10.3390/cancers16234077.


Evaluation of Two Different Approaches for Selecting Patients for Postoperative Radiotherapy in Deep-Seated High-Grade Soft Tissue Sarcomas in the Extremities and Trunk Wall.

Thorn A, Iljazi A, Engelmann B, Aggerholm-Pedersen N, Baad-Hansen T, Petersen M Cancers (Basel). 2024; 16(19).

PMID: 39410043 PMC: 11475416. DOI: 10.3390/cancers16193423.


De Novo Natural Language Processing Algorithm Accurately Identifies Myxofibrosarcoma From Pathology Reports.

Lindsay S, Madison C, Ramsey D, Doung Y, Gundle K Clin Orthop Relat Res. 2024; 483(1):80-87.

PMID: 39360774 PMC: 11658748. DOI: 10.1097/CORR.0000000000003270.


A Population-Based Long-Term Follow-Up of Soft Tissue Angiosarcomas: Characteristics, Treatment Outcomes, and Prognostic Factors.

Holm C, Orholt M, Talman M, Abebe K, Thorn A, Baad-Hansen T Cancers (Basel). 2024; 16(10).

PMID: 38791913 PMC: 11120488. DOI: 10.3390/cancers16101834.


Quality of Sarcoma Care: Longitudinal Real-Time Assessment and Evidence Analytics of Quality Indicators.

Heesen P, Studer G, Bode B, Windegger H, Staeheli B, Aliu P Cancers (Basel). 2023; 15(1).

PMID: 36612043 PMC: 9817921. DOI: 10.3390/cancers15010047.


References
1.
Dyrop H, Vedsted P, Safwat A, Maretty-Nielsen K, Hansen B, Jorgensen P . Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center. Acta Orthop. 2014; 85(6):657-62. PMC: 4259033. DOI: 10.3109/17453674.2014.957086. View

2.
Coindre J . Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006; 130(10):1448-53. DOI: 10.5858/2006-130-1448-GOSTSR. View

3.
Saebye C, Safwat A, Kaa A, Aggerholm Pedersen N, Keller J . Validation of a Danish version of the Toronto Extremity Salvage Score questionnaire for patients with sarcoma in the extremities. Dan Med J. 2014; 61(1):A4734. View

4.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

5.
Buvarp Dyrop H, Safwat A, Vedsted P, Maretty-Nielsen K, Hansen B, Jorgensen P . Cancer Patient Pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark. Health Policy. 2013; 113(1-2):110-7. DOI: 10.1016/j.healthpol.2013.09.012. View